![]() Sagent Pharmaceuticals Sagent Pharmaceuticals is focused on developing, manufacturing, sourcing and marketing pharmaceutical products. | |||
Founding Date | Founding Date 2006 | Founding Date 1982 | Founding Date 2001 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Schaumburg, US HQ | Locations Macquarie Park, AU HQ Wien, AT Mechelen, BE Toronto, CA Beijing, CN Prague, CZ Vantaa, FI see more | |
Employees | Employees 2261% increase | Employees 4,996 | Employees 1,0207% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 13 b | Valuation ($) 222 m |
Financial | |||
Revenue (est.) | Revenue (est.) $318.3m (FY, 2015) | Revenue (est.) $2.4b (FY, 2025) | Revenue (est.) $348.7m (FY, 2025) |
Cost of goods | Cost of goods $230.6m (FY, 2015) | Cost of goods $524.8m (FY, 2025) | Cost of goods $163.8m (FY, 2025) |
Gross profit | Gross profit $87.7m (FY, 2015) | Gross profit $1.9b (FY, 2025) | Gross profit $154.3m (FY, 2025) |
Net income | Net income ($21.9m) (FY, 2015) | Net income $388.9m (FY, 2025) | Net income ($22.7m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 70m | Total funding raised N/A | Total funding raised $ 29.6m |

Cochlear is a company developing implantable hearing solutions.
View company
Inogen is a manufacturer and an accredited homecare provider dedicated to oxygen therapy.
View company